J2501 Injection, paricalcitol, 1 mcg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Paricalcitol
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, paricalcitol, 1 mcg | yes |
Related codes in J25
- J2502 Injection, pasireotide long acting, 1 mg
- J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507 Injection, pegloticase, 1 mg
- J2508 Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510 Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2515 Injection, pentobarbital sodium, per 50 mg
- J2516 Injection, pentamidine isethionate, 1 mg
- J2540 Injection, penicillin g potassium, up to 600,000 units
- J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2545 Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
- J2547 Injection, peramivir, 1 mg
- J2550 Injection, promethazine hcl, up to 50 mg
- J2560 Injection, phenobarbital sodium, up to 120 mg
- J2561 Injection, phenobarbital sodium (sezaby), 1 mg
- J2562 Injection, plerixafor, 1 mg
- J2590 Injection, oxytocin, up to 10 units
- J2596 Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit
- J2597 Injection, desmopressin acetate, per 1 mcg
- J2598 Injection, vasopressin, 1 unit
- J2599 Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit